Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.85 - $3.73 $46.9 Million - $61.4 Million
-16,459,965 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.24 - $5.18 $16.4 Million - $26.2 Million
5,052,783 Added 44.29%
16,459,965 $55.5 Million
Q3 2021

Nov 15, 2021

BUY
$3.94 - $5.84 $38.2 Million - $56.6 Million
9,691,201 Added 564.76%
11,407,182 $58.2 Million
Q1 2021

May 17, 2021

SELL
$5.03 - $8.8 $45.5 Million - $79.6 Million
-9,045,612 Reduced 84.05%
1,715,981 $10.7 Million
Q4 2020

Feb 12, 2021

BUY
$4.04 - $5.31 $39 Million - $51.3 Million
9,661,593 Added 878.33%
10,761,593 $52.6 Million
Q3 2020

Nov 13, 2020

BUY
$3.64 - $7.76 $4 Million - $8.54 Million
1,100,000 New
1,100,000 $4.63 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.